MOVING LIFE SCIENCE INNOVATIONS
FROM DISCOVERY TO DEVELOPMENT TO DELIVERY
OUR VISION OF THE FUTURE: Arizona is a top-ten life science state.
OUR MISSION: AZBio supports the needs of Arizona’s growing life science ecosystem.
OUR MEMBERS: AZBio Members make an impact. They discover, develop and deliver health innovations including medicines, medical devices, diagnostics, and a wide range of health technologies. Our members also include economic development partners, educators, investors, leading business and philanthropic organizations, and patient advocacy organizations. AZBio Members employ over 365,000 Arizonans who are working together to make life better for people in Arizona and around the world.
Our industry sector generated over $43.64 billion in Economic Impact in 2023.
That's up over 88% from 2016 and growing at a Compound Annual Growth Rate of 9.5%.
Arizona’s bioscience industry (not including our hospitals) employed 40,399 in 2023 across 3,652 state business establishments, representing a rapid 24.6 percent increase in employment since 2019 and placing the state among the leaders in employment growth. The average wage in the bioscience industry was $102,161—53 percent higher than the state’s private sector average. View More of Arizona's Bioscience Industry Data
IN THE LOOP
AZBio In The Loop is your opportunity to stay up to date on what is happening across Arizona's Life Science and Healthcare Community.
SubscribeAZBio Members Are Making LIFE Better
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry.
AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, and other professions involved in the biosciences are the key drivers of the growth of Arizona's life science sector. As the unified voice of our industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed.
AZBio works nationally and globally with the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association (MDMA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and leading patient advocacy organizations.
Through these relationships, AZBio has access to information, contacts, resources, cost saving programs, and the global bioscience and medtech community.
Success Stories – Good News from Arizona’s BioIndustry
President Trump Signs Historic Executive Order to Advance Women’s Health, Championed by First Lady Melania Trump
WASHINGTON, D.C.—OCTOBER 19, 2026—President Donald J. Trump, with the leadership and support of First Lady Melania Trump, today signed an executive order, Advancing Women’s Health to Improve Outcomes in All Phases of Life, which directs the U.S. Department of Health and Human Services (HHS) to establish a new Women’s Health Division within the National Institutes […]
FDA-SEC Issues Memorandum of Understanding. How Does this Change their Information Sharing and What Does the Future Hold for Life Science Companies?
On August 31, 2026, the U.S. Food and Drug Administration (FDA) and the U.S. Securities and Exchange Commission (SEC) entered a Memorandum of Understanding (MOU) to enhance cooperation in their regulatory and enforcement responsibilities to improve market oversight and compliance.
BioLab Holdings Launches EmeraNova™ to Advance the Future of Tissue Restoration
Expanded vision reflects focus beyond wound care to advancing innovation across the full tissue restoration journey
FDA Launches the Rare Disease Framework Initiative to Develop a Holistic, Fit-For-Purpose Framework for Rare Disease Drug Development Effort begins by Soliciting Public Feedback
The U.S. Food and Drug Administration, a division within the U.S. Department of Health and Human Services (HHS), today announced the Rare Disease Framework Initiative to reimagine the development of drugs and biologics for rare diseases. As outlined in a new white paper, the Initiative will develop an optimized, fit-for-purpose framework that reflects the realities […]
Events
- PDX - Product Development Expo 2026
        Oct 20, 2026 - Mesa - Connect Labs Phoenix Open House
        Oct 22, 2026 - Phoenix - How to Calculate Sample Sizes and Statistical Power for Research Studies and Program Evaluations
        Oct 27, 2026 - - The Nature of AI’s Intelligence
        Oct 27, 2026 - Tempe - PADT Nerdtoberfest
        Oct 28, 2026 - Tempe









































































